HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Languages: English, Hindi, Punjabi and Russian
Locations: Howell, NJ
Call Howell, NJ: (732) 367-1535
Manmeet Singh Ahluwalia, MD, is part of the oncology team at Regional Cancer Care Associates (RCCA) in Howell, New Jersey. He is board-certified in Internal Medicine, Hematology, and Oncology, and has expertise in treating a wide range of cancer types and non-malignant hematology conditions. Medicine is his calling, and he values the opportunity to build deep relationships with patients and their families. Schedule an appointment with Dr. Ahluwalia today.
Like many other RCCA physicians, Dr. Ahluwalia specializes in treating a wide array of hematologic and oncologic conditions. His expertise covers the diagnosis and treatment of both solid tumors and blood disorders, including the following:
In treating these and other conditions, Dr. Ahluwalia prioritizes the latest evidence-based therapies. He delivers chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and other advanced treatments. These are backed up by a care model centered on compassion. He gets involved with patient support, helping them coordinate care throughout the treatment process. He also offers pain control, symptom management, and other services to help patients through a difficult time.
Dr. Ahluwalia was awarded Degree with Honors/Gold Medal from I.M. Sechenov Moscow Medical Academy in Moscow, Russia. This award is an acknowledgement of academic excellence and high distinction in medical training.
H2: Professional Background & Academic Achievements
Dr. Ahluwalia is an active member of several national and international medical associations. His memberships include:
Organizations like ASCO, ASH, and AMA are dedicated to improving knowledge of and treatments for cancer. As a member, Dr. Ahluwalia has access to the most current information and resources. This helps him stay up to date with the latest discoveries, changes in clinical guidelines, and more. He also can collaborate with thousands of other oncologists and medical researchers in the national and global community, for joint learning and a higher level of patient care.
Medicine is more than a profession for Dr. Ahluwalia; it is a calling. “Medicine combines scientific discovery with the opportunity to make a meaningful impact in people’s lives,” he says, enjoying the intellectual challenge just as much as he does the human connection. Dr. Ahluwalia chose oncology because it demands “clinical expertise, compassion, resilience, and the ability to build deep, trusting relationships with patients and their families.”
“I consider it a privilege to care for my patients,” he adds, “and to be part of their journey through diagnosis, treatment, and healing. Their courage inspires me every day.”
It is this opportunity for connection that makes Dr. Ahluwalia’s work feel meaningful, and it extends beyond his patients. RCCA embraces a team-based model of care that emphasizes collaboration between a wide range of specialists including surgeons, radiation oncologists, radiologists, pathologists, and more. Oncologists also maintain close partnerships with external care centers.
“This approach to care ensures that patients have access to the highest levels of care,” says Dr. Ahluwalia, “and that we can offer specialized resources when needed.”
RCCA oncologists also work closely with their clinical research team. Dr. Ahluwalia regularly participates in clinical trials, which allow patients to benefit from cutting-edge new therapies while contributing to research. In his words: “Commitment to innovation means that our patients benefit not only from today’s best practices, but also from the potential treatments of tomorrow.”
When it comes to innovation, now is an incredibly exciting time in oncology. Advances in targeted therapies and personalized medicine are transforming the ways in which cancer can be treated, creating new options to treat and cure diagnoses that were previously incurable. Dr. Ahluwalia is able to bring these innovations directly to his patients. “Seeing them regain hope and strength is the most rewarding part of what I do,” he says.
He also takes the time to help patients understand their options. Cancer treatment can be overwhelming, with many new terms and concepts. By educating and answering questions, Dr. Ahluwalia helps patients feel more confident and engaged with their treatment.
“For those newly diagnosed with cancer,” adds Dr. Ahluwalia: “You are not alone. We are here to guide you through every step, offering not just medical care but true partnership, clarity, and compassion.”
“My philosophy of care is centered on the whole person. I believe every patient deserves a treatment plan that reflects not just the best available science, but also their individual goals, concerns, and life circumstances. I take the time to listen, to understand, and to ensure that my patients feel informed, supported, and empowered throughout their care.”
Dr. Ahluwalia, MD, treats patients at RCCA in Howell, NJ.
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.